Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential effects of metformin-mediated BSEP repression on pravastatin and bile acid pharmacokinetics in humans: A randomized controlled trial. | Clin Transl Sci | 2022 | 35899436 | PubTator, text mining | PubMed |
| Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy. | Clin Pharmacokinet | 2022 | 35895276 | PubTator, text mining | PubMed |
| Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks. | Pharmaceuticals (Basel) | 2022 | 35893737 | PubTator, text mining | PubMed |
| Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus. | Genes (Basel) | 2022 | 35893047 | PubTator, text mining | PubMed |
| Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs. | Pharmaceutics | 2022 | 35890396 | PubTator, text mining | PubMed |
| Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta. | Pharmaceutics | 2022 | 35890272 | PubTator, text mining | PubMed |
| Metabolic Action of Metformin. | Pharmaceuticals (Basel) | 2022 | 35890109 | PubTator, text mining | PubMed |
| Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses. | Pharmaceuticals (Basel) | 2022 | 35890085 | PubTator, text mining | PubMed |
| Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients. | Pharmaceuticals (Basel) | 2022 | 35890074 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Enhanced Imputation Identifies 85 Metabolite Associations in the Alpine CHRIS Cohort. | Metabolites | 2022 | 35888728 | PubTator, text mining | PubMed |
| Protein Abundance of Drug Transporters in Human Hepatitis C Livers. | Int J Mol Sci | 2022 | 35887291 | PubTator, text mining | PubMed |
| Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis. | Biomedicines | 2022 | 35884999 | PubTator, text mining | PubMed |
| Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia. | Cancers (Basel) | 2022 | 35884363 | PubTator, text mining | PubMed |
| Microcystin-LR incorporated into colonic cells through probenecid-sensitive transporters leads to upregulated MCP-1 expression induced by JNK activation. | Toxicol Rep | 2022 | 35875256 | PubTator, text mining | PubMed |
| Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma. | Front Oncol | 2022 | 35875102 | PubTator, text mining | PubMed |
| Screening of Prognostic Markers for Hepatocellular Carcinoma Patients Based on Multichip Combined Analysis. | Comput Math Methods Med | 2022 | 35872941 | PubTator, text mining | PubMed |
| PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo. | Cancer Lett | 2022 | 35872263 | PubTator, text mining | PubMed |
| Coordination of zygotic genome activation entry and exit by H3K4me3 and H3K27me3 in porcine early embryos. | Genome Res | 2022 | 35868641 | PubTator, text mining | PubMed |
| Antitumor effects of pyrrole-imidazole polyamide modified with alkylating agent on prostate cancer cells. | Biochem Biophys Res Commun | 2022 | 35868070 | PubTator, text mining | PubMed |
| Pharmacokinetics of Imeglimin in Caucasian and Japanese Healthy Subjects. | Clin Drug Investig | 2022 | 35867199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=29